Study of the Effect of Ivacaftor on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation
Clinical trial NCT01262352 · COMPLETED
Trial details
- NCT number
- NCT01262352
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-11-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.